Yasmina Barral

ORCID: 0009-0003-0513-645X · 5 papers in corpus
observational 2025
Exploring Oxidative Stress in Different Endometriosis Phenoptypes: Insights from Ovarian and Systemic Perspectives by the Study of SIRT3
International journal of molecular sciences ·doi:10.3390/ijms26189110

Endometriosis affects about 10% of reproductive-aged women, characterized by endometrial-like tissue outside the uterus, leading to chronic inflammation. The exact cause remains unknown, though genetic and epigenetic factors are increasingl…

case-report 2025
Unusual ovarian hyperstimulation syndrome presentation: Pleural effusion without ascites. A case report
World journal of clinical cases ·doi:10.12998/wjcc.v13.i8.100028

BACKGROUND: Ovarian hyperstimulation syndrome (OHSS) is a life-threatening complication that can occur in the luteal phase or early pregnancy after controlled ovarian stimulation. This case report highlights a unique manifestation of OHSS i…

observational 2024
Histological ovarian features and hormonal determinations in assigned females at birth transgender individuals according to different testosterone preparations
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1458846

INTRODUCTION: Distinct androgen formulations have been used as gender-affirming hormone treatment, but little is known about the specific changes that may occur in the ovary depending on the testosterone preparation used. The study aims to …

observational 2024
P-311 Impact of adenomyosis on reproductive outcomes applying the revised Morphological Uterus Sonographic Assessment criteria in fresh donor oocyte recipients pretreated with GnRH agonist
·doi:10.1093/humrep/deae108.676

Abstract Study question Could the diagnosis of adenomyosis (AD) impact reproductive outcomes when applying the revised Morphological Uterus Sonographic Assessment (MUSA) criteria in fresh donor oocyte cycles? Summary answer Adenomyosis diag…

observational 2023
Current status of fertility preservation in a Spanish tertiary public hospital: multidisciplinary approach and experience in over 1500 patients
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico ·doi:10.1007/s12094-023-03330-2

PURPOSE: Currently, 15% of gynaecological and 9% of haematological malignancies are diagnosed before the age of 40. The increased survival rates of cancer patients who are candidates for gonadotoxic treatments, the delay in childbearing to …